4//SEC Filing
Topper James N 4
Accession 0000950170-25-082454
CIK 0001783183other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:56 PM ET
Size
11.8 KB
Accession
0000950170-25-082454
Insider Transaction Report
Form 4
Topper James N
Director
Transactions
- Award
Common Stock
2025-06-03+10,500→ 42,596 total - Award
Stock Option (Right to Buy)
2025-06-03+17,500→ 17,500 totalExercise: $4.95Exp: 2035-06-02→ Common Stock (17,500 underlying)
Holdings
- 1(indirect: By FHMLS IX, L.L.C.)
Common Stock
- 59,403(indirect: By Frazier Life Sciences X, L.P.)
Common Stock
- 5,827,415(indirect: By Frazier Life Sciences IX, L.P.)
Common Stock
- 3,912(indirect: By LLC)
Common Stock
Footnotes (6)
- [F1]The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The shares reported herein are held of record by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F3]The shares reported herein are held of record by Frazier Life Sciences IX, L.P. FHMLS IX, L.P. is the general partner of Frazier Life Sciences IX, L.P. and FHMLS IX, L.L.C. is the general partner of FHMLS IX, L.P. The Reporting Person is one of two managing members of FHMLS IX, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F4]The shares reported herein are held of record by FHMLS IX, L.L.C. The Reporting Person is one of two managing members of FHMLS IX, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F5]The Reporting Person is a manager of Topper Group III LLC and has voting and investment power of the securities held by Topper Group III LLC.
- [F6]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the firstanniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vestingdate.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001341382
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:56 PM ET
- Size
- 11.8 KB